<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.SourceSummaryOutput xmlns:ns2="local"><SourceId>1309190</SourceId><Description>Clinical Trial Registry</Description><Title>NCT01635621: A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's Disease</Title><Origin>UCB SA</Origin><PublicationDetails><Year>2012</Year></PublicationDetails></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.SourceSummaryOutput>